Literature DB >> 9076652

More is better: counseling participation and the effectiveness of outpatient drug treatment.

R Fiorentine1, M D Anglin.   

Abstract

Counseling is a cornerstone of virtually all drug treatment modalities, yet there is relatively little research examining counseling effectiveness. This article addresses a simple question concerning counseling: Is more frequent participation in counseling associated with better treatment outcomes? Findings from an evaluation of the Los Angeles Target Cities Project indicate that monthly counseling frequency varied substantially for participants of outpatient programs, and more frequent counseling was associated with lower levels of relapse to drug use, even for individuals who successfully completed the treatment program. The association between counseling frequency and relapse did not attend to all types of counseling, however, but mainly to group and individual counseling. More frequent attendance of family counseling and 12-step meetings during the outpatient treatment phase did not significantly lower the probability of relapse. Frequent participants of group and individual counseling who continued to be frequent participants of 12-step meetings during the posttreatment period had the lowest probability of relapse. The policy implications of the findings and directions for further research are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 9076652     DOI: 10.1016/s0740-5472(96)00109-2

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  10 in total

1.  Participation in treatment and Alcoholics Anonymous: a 16-year follow-up of initially untreated individuals.

Authors:  Rudolf H Moos; Bernice S Moos
Journal:  J Clin Psychol       Date:  2006-06

2.  Program structure and counselor-client contact in outpatient substance abuse treatment.

Authors:  Danica K Knight; Kirk M Broome; D Dwayne Simpson; Patrick M Flynn
Journal:  Health Serv Res       Date:  2008-04       Impact factor: 3.402

3.  Pay-for-performance in a community substance abuse clinic.

Authors:  Ryan Vandrey; Maxine L Stitzer; Shauna P Acquavita; Patricia Quinn-Stabile
Journal:  J Subst Abuse Treat       Date:  2011-04-12

4.  Treatment program operations and costs.

Authors:  Kirk M Broome; Danica K Knight; George W Joe; Patrick M Flynn
Journal:  J Subst Abuse Treat       Date:  2011-12-05

5.  Predictors of change in the provision of services within outpatient substance abuse treatment programs.

Authors:  Danica Kalling Knight; Jennifer R Edwards; Patrick M Flynn
Journal:  J Public Health Manag Pract       Date:  2010 Nov-Dec

6.  Women-focused treatment agencies and process improvement: Strategies to increase client engagement.

Authors:  Jennifer P Wisdom; Kim Hoffman; Elke Rechberger; Kay Seim; Betta Owens
Journal:  Women Ther       Date:  2009-01-01

7.  The impact of managed care on the substance abuse treatment patterns and outcomes of Medicaid beneficiaries: Maryland's HealthChoice program.

Authors:  Susan L Ettner; Gabrielle Denmead; Joan Dilonardo; Hui Cao; Albert J Belanger
Journal:  J Behav Health Serv Res       Date:  2003 Jan-Feb       Impact factor: 1.505

8.  Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management?

Authors:  Roger D Weiss; Margaret L Griffin; Jennifer Sharpe Potter; Dorian R Dodd; Jessica A Dreifuss; Hilary S Connery; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2014-04-24       Impact factor: 4.492

9.  Gender Comparisons Among Asian American and Pacific Islander Patients in Drug Dependency Treatment.

Authors:  Yun Han; Veronique Lin; Fei Wu; Yih-Ing Hser
Journal:  Subst Use Misuse       Date:  2016-04-12       Impact factor: 2.164

10.  Analyzing the impact of social factors on homelessness: a fuzzy cognitive map approach.

Authors:  Vijay K Mago; Hilary K Morden; Charles Fritz; Tiankuang Wu; Sara Namazi; Parastoo Geranmayeh; Rakhi Chattopadhyay; Vahid Dabbaghian
Journal:  BMC Med Inform Decis Mak       Date:  2013-08-23       Impact factor: 2.796

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.